United States Biotechnology & Medical Research

MetaVia Inc (MTVA)

Track

MetaVia Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in June and May 2025, involving share acquisitions by the Chief Financial Officer and DONG-A ST CO., LTD. These historical movements represent the final recorded equity adjustments for the firm.
Ticker: MTVA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MetaVia Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Woodworth Marshall H Chief Financial Officer Officer
Transaction date
Purchase
Price
406.93
Quantity 47,862 -3.9%
Value US$601,217
2.1
DONG-A ST CO., LTD Large shareholder
Transaction date
Purchase
Price
480.47
Quantity 93,868 +1.8%
Value US$1,074,857
2.1
DONG-A ST CO., LTD Large shareholder
Transaction date
Sale
Price
373.35
Quantity 84,363 +13.4%
Value US$449,526
2.1
DONG-A ST CO., LTD Large shareholder
Transaction date
Purchase
Price
3.13
Quantity 2,544,530 +90.8%
Value US$7,964,379
Reno Seth Chief Commercial Officer Officer
Transaction date
Purchase
Price
7.00
Quantity 14,286 +357.1%
Value US$100,002
Gullans Steven R. Ph.D. Interim President & CEO Executive Director
Transaction date
Purchase
Price
7.00
Quantity 71,429 +8.3%
Value US$500,003
Hawryluk P. Kent
Transaction date
Purchase
Price
9.47
Quantity 25,000 +43.9%
Value US$236,750
Gullans Steven R. Ph.D.
Transaction date
Purchase
Price
9.47
Quantity 52,798 +6.6%
Value US$499,997
LICHTINGER PEDRO
Transaction date
Purchase
Price
9.47
Quantity 10,559 +21.4%
Value US$99,994
SASSINE ANDY
Transaction date
Purchase
Price
9.47
Quantity 21,119 +18.3%
Value US$199,997
Hawryluk P. Kent Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 25,000 +78.4%
Value US$250,000
Gullans Steven R. Ph.D. Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 500,000 +163.4%
Value US$5,000,000
Sooch Mina President & CEO Executive Director
Transaction date
Purchase
Price
10.00
Quantity 52,500 +8.2%
Value US$525,000
MATHIESEN JEFFREY S Chief Financial Officer Officer
Transaction date
Purchase
Price
10.00
Quantity 4,000 +101.9%
Value US$40,000
Bisgaier Charles PhD Chair & Chief Scientific Off. Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 51,750 +4.3%
Value US$517,500
LICHTINGER PEDRO Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 10,000 +25.5%
Value US$100,000
KOUSKY KENNETH W Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 1,000 +inf%
Value US$10,000
Reno Seth Chief Commercial Officer Officer
Transaction date
Purchase
Price
10.00
Quantity 4,000 +inf%
Value US$40,000
Lowenschuss David Chief Legal Off. & Secretary Officer
Transaction date
Purchase
Price
10.00
Quantity 11,120 +1.4%
Value US$111,200
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-04 2025-06-04 B Purchase
1.6
Woodworth Marshall H

Chief Financial Officer

Officer
47,862 -3.9%
406.93
US$601,217 		47,862 -3.9% 406.93 US$601,217
2025-05-20 2025-05-08 B Purchase
2.1
DONG-A ST CO., LTD
Large shareholder
93,868 +1.8%
480.47
US$1,074,857 		93,868 +1.8% 480.47 US$1,074,857
2024-09-20 2024-09-12 S Sale
2.1
DONG-A ST CO., LTD
Large shareholder
84,363 +13.4%
373.35
US$449,526 		84,363 +13.4% 373.35 US$449,526
2024-06-25 2024-06-23 B Purchase
2.1
DONG-A ST CO., LTD
Large shareholder
2,544,530 +90.8%
3.13
US$7,964,379 		2,544,530 +90.8% 3.13 US$7,964,379
2018-02-12 2018-02-08 B Purchase Reno Seth

Chief Commercial Officer

Officer
14,286 +357.1%
7.00
US$100,002 		14,286 +357.1% 7.00 US$100,002
2018-02-12 2018-02-08 B Purchase Gullans Steven R. Ph.D.

Interim President & CEO

Executive Director
71,429 +8.3%
7.00
US$500,003 		71,429 +8.3% 7.00 US$500,003
2017-03-14 2017-03-10 B Purchase Hawryluk P. Kent
25,000 +43.9%
9.47
US$236,750 		25,000 +43.9% 9.47 US$236,750
2017-03-14 2017-03-10 B Purchase Gullans Steven R. Ph.D.
52,798 +6.6%
9.47
US$499,997 		52,798 +6.6% 9.47 US$499,997
2017-03-14 2017-03-10 B Purchase LICHTINGER PEDRO
10,559 +21.4%
9.47
US$99,994 		10,559 +21.4% 9.47 US$99,994
2017-03-14 2017-03-10 B Purchase SASSINE ANDY
21,119 +18.3%
9.47
US$199,997 		21,119 +18.3% 9.47 US$199,997
2016-08-12 2016-08-10 B Purchase Hawryluk P. Kent Non-Executive Director
25,000 +78.4%
10.00
US$250,000 		25,000 +78.4% 10.00 US$250,000
2016-08-12 2016-08-10 B Purchase Gullans Steven R. Ph.D. Non-Executive Director
500,000 +163.4%
10.00
US$5,000,000 		500,000 +163.4% 10.00 US$5,000,000
2016-08-12 2016-08-10 B Purchase Sooch Mina

President & CEO

Executive Director
52,500 +8.2%
10.00
US$525,000 		52,500 +8.2% 10.00 US$525,000
2016-08-12 2016-08-10 B Purchase MATHIESEN JEFFREY S

Chief Financial Officer

Officer
4,000 +101.9%
10.00
US$40,000 		4,000 +101.9% 10.00 US$40,000
2016-08-12 2016-08-10 B Purchase Bisgaier Charles PhD

Chair & Chief Scientific Off.

Executive Director Large shareholder
51,750 +4.3%
10.00
US$517,500 		51,750 +4.3% 10.00 US$517,500
2016-08-12 2016-08-10 B Purchase LICHTINGER PEDRO Non-Executive Director
10,000 +25.5%
10.00
US$100,000 		10,000 +25.5% 10.00 US$100,000
2016-08-12 2016-08-10 B Purchase KOUSKY KENNETH W Non-Executive Director
1,000 +inf%
10.00
US$10,000 		1,000 +inf% 10.00 US$10,000
2016-08-12 2016-08-10 B Purchase Reno Seth

Chief Commercial Officer

Officer
4,000 +inf%
10.00
US$40,000 		4,000 +inf% 10.00 US$40,000
2016-08-12 2016-08-10 B Purchase Lowenschuss David

Chief Legal Off. & Secretary

Officer
11,120 +1.4%
10.00
US$111,200 		11,120 +1.4% 10.00 US$111,200
Explore more

More insider trading research around MetaVia Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America